Infectious & Parasitic Diseases

EastHORN has an extensive background in infectious diseases. The majority of the studies have been in Phases II and III. Areas of particular strength are:

  • Aspergillosis
  • Bacterial Complications in Cystic Fibrosis
  • Bacterial Vaginosis
  • Candidiasis
  • COVID-19 Vaccine
  • Community Acquired Pneumonia
  • Cytomegalovirus (CMV) infection
  • Hepatitis B
  • Hepatitis C
  • HIV
  • Hospital Acquired Pneumonia
  • Human Papilloma Virus
  • Influenza
  • Intra-abdominal Infections
  • Mild or Moderate COVID-19
  • Meningitis
  • MRSA infection
  • Osteomyelitis
  • Pneumonia (HAP/CAP)
  • Skin and Soft Tissue Infections
  • Tuberculosis
  • Urinary Track Infections
  • Viral rhinitis

EastHORN has experience in the following categories of anti-infective agents:

  • Interferons
  • Protease Inhibitors
  • Vaccines
  • Antibiotics
  • Hospital acquired infection control